Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 16, 2016 FORM 8-K
DEF 14A May 9, 2016 DEFINITIVE PROXY STATEMENT
PRE 14A Apr 25, 2016 PRELIMINARY PROXY STATEMENT
10-K Mar 21, 2016 FORM 10-K
8-K Mar 16, 2016 FORM 8-K
4 Feb 12, 2016 FORM 4 SUBMISSION
SC 13G/A Jan 19, 2016 SIGNAL GENETICS, INC.
EFFECT Dec 2, 2015
EFFECT Dec 2, 2015
EFFECT Dec 2, 2015
CORRESP Dec 2, 2015
8-K Nov 30, 2015 FORM 8-K
4 Nov 23, 2015 FORM 4 SUBMISSION
POS AM Nov 23, 2015 POS AM
POS AM Nov 23, 2015 POS AM
CORRESP Nov 20, 2015
10-Q Nov 13, 2015 FORM 10-Q
8-K Nov 13, 2015 FORM 8-K FILING DOCUMENT
8-K Sep 24, 2015 FORM 8-K
8-K Sep 23, 2015 FORM 8-K FILING DOCUMENT
8-K Sep 17, 2015 FORM 8-K
8-K Sep 8, 2015 FORM 8-K FILING DOCUMENT
10-Q Aug 14, 2015 FORM 10-Q
4 Aug 14, 2015 FORM 4 SUBMISSION
8-K Aug 12, 2015 FORM 8-K FILING DOCUMENT
← Newer Page 29 of 33 · 821 filings Older →